Photocure ASA

Report Publication Announcement • Apr 6, 2017

Photocure ASA: Annual accounts

Photocure ASA: Annual accounts

Oslo, 6 April 2017: Photocure ASA (OSE: PHO), has published the annual accounts

and annual report for the financial year 2016.

The annual accounts and annual report for the financial year 2016 are enclosed

with this notification and made available on the company's website,

www.photocure.com.

For further information, please contact:

Photocure

CFO Erik Dahl

Tel: +47 450 55 000, Email: ed@photocure.no

About Photocure ASA

Photocure, headquartered in Oslo Norway, is a specialty pharmaceutical company

and world leader in photodynamic technology. Based on its unique proprietary

Photocure Technology® platform, Photocure develops and commercializes highly

selective and effective solutions in disease areas with high-unmet medical need,

such as bladder cancer, HPV and precancerous cervical lesions, and skin

conditions. Photocure's aim is to provide solutions which can improve health

outcomes for patients worldwide. The company is listed on the Oslo Stock

Exchange (OSE: PHO). Information about Photocure is available at

www.photocure.com.

This information is subject to the disclosure requirements pursuant to section

5-12 of the Norwegian Securities Trading Act.